Patent Issued For "In Vivo Biosensor"

DBC's second patent, US 9,883,826 titled "In Vivo Biosensor", was issued on February 6, 2018.  This patent describes critical aspects of the technology for combining our aptamer-based biosensing element with our proprietary micro-fabricated in vivo sensor substrates.

Powered by